Johnson Matthey

Partial; catalysis, precious-metals, and advanced-materials major with a defined biocatalysis business serving pharma and fine-chemicals customers (transaminases, ketoreductases, imine reductases, and engineered enzyme cascades for chiral APIs). Biocatalysis is one segment within a much larger chemistry- and catalyst-driven business.